Article
A GLP-1 price change needs a comparable earlier offer
Two different numbers do not necessarily show a price increase or decrease. The medication, formulation, commitment, fees and billing period must be comparable before a historical reading can be interpreted as a changed offer.
Research by Treatment Registry · Our method
Published October 2026 · Updated October 2026
Observation window: August 2026–October 2026. The newest reading does not mean every program was checked then.
Contents
Reading
Keep the earlier observation
A price directory that overwrites yesterday's number cannot explain how the offer changed. Treatment Registry preserves dated readings so a visitor can compare the earlier source with the later one. Corrections are also recorded, because fixing our interpretation is different from a company changing its price.
Of 1139 program records, 520 have more than one observation. That describes the amount of history available, not the number of price changes. A second reading may confirm an unchanged figure or add a previously unchecked field.
Eden shows why fees belong in the history
The older Eden semaglutide record described a medication figure plus a required membership. The source rechecked in October 2026 presents a monthly offer without a separate membership fee. Looking only at the medication number would miss the change in the structure of the offer.
The Eden tirzepatide record also has a new published price. The useful comparison is the dated offer and its components, rather than a claim about what every existing patient now pays. Existing accounts can have their own terms; a public website reading is evidence of what was advertised when we checked it.
Control for the terms before computing a difference
A shorter commitment can cost more per month while requiring less money upfront. A four-week plan can have a similar-looking figure but a different annual payment schedule. A new formulation can carry a different price without the earlier product having changed at all.
For a defensible comparison, keep the following aligned: drug and form, supply period, billing term, whether insurance is required, medication inclusion and mandatory fees. Where the match fails, describe the change in words rather than presenting a misleading percentage.
The changes log records events across the register. Its entries are useful leads for research, not a ready-made market index. Building an index would require a stable sample and rules for missing offers, provider exits and changed packages.
Read dates as dates, not freshness badges
The latest observation in a dataset does not refresh every other record. This analysis uses readings from August 2026–October 2026, with the named Eden example checked in October 2026. An article's publication date tells you when the explanation was written; it does not establish when every underlying provider was last reviewed.
We do not infer price history from an imported number without our own quote, count a corrected parsing error as a market move, or assume a missing page means a provider stopped selling the treatment. Those situations belong in the limitations beside the finding.
If you want to compare current offers, start with the individual provider profiles and their source dates. If you want to understand a change, follow the record's observation history and methodology.
Notes
Cite this
Treatment Registry. (2026). A GLP-1 price change needs a comparable earlier offer. Retrieved [your access date], from https://treatmentregistry.com/articles/glp-1-price-changes